Findings on the relationship between HIF-1α and mitochondrial dysfunction during MV- and sepsis-related diaphragm dysfunction may reveal how clinicians can best manipulate mitochondrial function enhancement through applicable HIF-1α inhibitors [51,52] to improve sepsis-related diaphragm dysfunction in patients undergoing MV. This evidence concerns the gene HIF1A and Sepsis.